MYREFEN Mefenamic Acid 50mg / mL Suspension 60mL
RXDRUG-DRP-244
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications
Mild to moderate pain; Primary dysmenorrhea, Osteoarthritis, Rheumatoid arthritis
Dosage and Administration
Children over 6 months of age: 25mg/kg body weight daily in divided doses.
It should not be continued for longer than 7 days or as prescribed by the physician.
Administer with food.
Contraindications
Hypersensitivity to mefenamic acid, or any component of the formulation. Refer to manufacturer labeling for further detail.
Common side-effects
Dizziness, Headache, Pruritus, Skin rash, Fluid retention, GI upset
Storage
Store between 15-30°C.
MedsGo Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Features
Brand
Myrefen
Full Details
Dosage Strength
50 mg / mL
Drug Ingredients
- Mefenamic Acid
Drug Packaging
Suspension 60ml
Generic Name
Mefenamic Acid
Dosage Form
Suspension
Registration Number
DRP-244
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply